FDA-Drug2025-01-15Class II
Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ
Rising Pharma Holding, Inc.
Hazard
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Sold states
Nationwide
Affected count
244,460 bottles
Manufactured in
2 Tower Center Blvd Ste 1401, East Brunswick, NJ, United States
Products
Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0190-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief